Press Release: Skila’s Karen Massand to Participate in Panel Discussion at 18th Annual NYBA 2009 Meeting

Skila on Twitter

Press Release

Skila’s Karen Massand to Participate in Panel Discussion at 18th Annual NYBA 2009 Meeting

Morris Plains, NJ, April 16, 2009 – On April 21, 2009, Skila’s Karen Massand, Managing Director Strategic Advisory, will participate in a panel discussion, “Pharma & Biotech on the Web” at the New York Biotechnology Association (NYBA) 18th Annual Meeting being held in New York City.

The panel will discuss the latest trends and future of the web as a major component of pharmaceutical and biotechnology companies’ operations and marketing strategies. Skila’s Karen Massand will discuss how life science organizations can become “partners of choice” and maximize alliances by leveraging the web for successful alliance management.

“A critical component of being partner focused and building strong alliance relationships is transparency,” says Karen Massand, Managing Director Strategic Advisory Services, Skila. “Web technology facilitates that transparency, allowing partners to optimize collaboration and build trust. Alliance partners that foster open communication, ensure alliance commitments are met and continuously monitor alliance health are ‘Partners of Choice’."

The NYBA 18th Annual Meeting will take place April 20 and 21, 2009 at the Marriott Marquis Hotel in New York City and will have a special focus on partnering between emerging biotech companies and large bio and pharmaceutical corporations. Highlights of the Annual Meeting will include a keynote address by Billy Tauzin, CEO of PhRMA (Pharmaceutical Research and Manufacturers Association) and an important plenary roundtable featuring senior licensing and business development executives from Merck, Pfizer and other major companies.

About Skila

Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.

Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.

BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.

To receive more information:

Do You Skila?